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ammary epithelial cells cultured on a concentrated
laminin-rich extracellular matrix formed 3D acinar
structures that matured to polarized monolayers
surrounding a lumen. In the absence of glucocorticoids
mature acinus formation failed and the expression of an
acinus-associated, activator protein 1 (AP1) and nuclear
factor 
 
 
 
B transcription factor DNA-binding proﬁle was lost.
Treatment with the JNK inhibitor, SP600125, caused similar
effects, whereas normal organization of the mammary epi-
thelial cells as acini caused JNK activation in a glucocorti-
M
 
coid-dependent manner. The forming acini expressed BRCA1,
GADD45
 
 
 
, MEKK4, and the JNK activating complex GADD
45
 
  
 
MEKK4 in a glucocorticoid-dependent fashion. JNK
catalyzed phosphorylation of c-Jun was also detected in the
acini. In addition, expression of 
 
 
 
4 integrin and in situ oc-
cupation of its promoter by AP1 components, c-Jun and Fos,
was glucocorticoid dependent. These results suggest that glu-
cocortocoid signaling regulates acinar integrity through a
pathway involving JNK regulation of AP1 transcription fac-
tors and 
 
 
 
4 integrin expression.
 
Introduction
 
Acini are spherical monolayers of epithelial cells that enclose
a central lumen (O’Brien et al., 2002). Culturing mouse
mammary epithelial cells on a laminin-rich Engelbreth-
Holm-Swarm (EHS) tumor-derived ECM generates such
acinar structures (Barcellos-Hoff et al., 1989; Blatchford et
al., 1999). The spatial organization of these structures is
maintained through cell–ECM and cell–cell interactions.
ECM detection by the epithelial cells occurs through inter-
actions with integrins. For instance, abrogating expression of
the collagen receptor, 
 
 
 
2
 
 
 
1
 
 integrin, caused MDCK acini to
apoptose because they could not detect the surrounding
ECM (Saelman et al., 1995). Essential cell–cell interactions
occur via the epithelial junctional complex of tight junctions,
adherens junctions, and desmosomes (O’Brien et al., 2002).
In 2D mammary epithelial model systems, glucocorticoids
contribute to such cell–cell interactions by inducing the
reorganization of tight and adherens junctions leading to
enhanced cell–cell adhesion and decreased paracellular per-
meability (Buse et al., 1995; Wong et al., 1999).
The supporting EHS matrix contains laminin, collagen
IV, entactin, and heparan sulfate proteoglycan (Kleinman
et al., 1986). Even single mammary epithelial cells are able
to assimilate information from this laminin-rich ECM and
can be induced to synthesize 
 
 
 
-casein (Streuli et al.,
1995). Function-blocking anti–
 
 
 
1-integrin antibodies in-
hibit mammary epithelial acinus organization and function
(Howlett et al., 1995). Indeed, expression of a dominant-
negative 
 
 
 
1-integrin in mouse mammary epithelium de-
layed the glandular maturation of late pregnancy, showed
deficient milk protein expression at the onset of lactation
and defects in epithelial cell polarity (Faraldo et al., 2000).
In vitro, treatment of mammary tumor cells loosely orga-
nized as 3D assemblies in culture on EHS ECM with an
inhibitory 
 
 
 
1-integrin antibody lead to a morphological
and functional reversion to a normal acinar phenotype
(Weaver et al., 1997). These reverted acini displayed a re-
organized cytoskeleton and a now functional basement
membrane. Thus, the ECM through interactions with in-
tegrins can determine the phenotype of the mammary epi-
thelial cell, regardless of its cellular genotype, i.e., normal
or malignant.
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During acinus formation, loss of luminal mammary epi-
thelial cells is due to apoptosis (Blatchford et al., 1999) and
autophagy (Mills et al., 2004). Debnath et al. (2002) dem-
onstrated that this apoptosis followed apicobasal cell polar-
ization and preceded proliferation suppression. Acinus
cavitation is accompanied by a redistribution of ECM con-
stituents to the periphery of the structure (Barcellos-Hoff et
al., 1989).
Through 
 
 
 
4-integrin mediated function, in hemidesmo-
somes, acini resist apoptotic insults to which monolayers
readily succumb (Weaver et al., 2002). Furthermore, func-
tion-blocking antibodies against desmocollin-2 and desmo-
glein-2, the principal desmosomal cadherins in mammary al-
veolar luminal cells, disrupted the formation of 3D spheres
of mammary epithelial Fsk-7.1 cells (Runswick et al., 2001).
Morphogenesis was also inhibited by function-blocking an-
tibodies against E-cadherin suggesting its critical depen-
dence on both desmosomal adhesion and cadherin junctions
(Runswick et al., 2001).
Mammary epithelial acinus maintenance and function re-
quires lactogenic hormones (Topper and Freeman, 1980):
prolactin will trigger the vectoral secretion of milk proteins
into their lumena (Blatchford et al., 1999); insulin or IGF-1
may be required to support cell survival (Farrelly et al.,
1999); and it seems that glucocorticoids could be required
for the formation and maintenance of tight junctional com-
plexes that would support acinus structure and function
(Buse et al., 1995). The present work investigates the role of
the glucocorticoids.
3D organization of mammary epithelial cells, as acini, is
shown to require glucocorticoids which activate the MAPK,
JNK. Acinus formation is compromised by a JNK inhibitor
and JNK activation is glucocorticoid dependent. JNK acti-
vates the activator protein 1 (AP1) component, c-Jun, and
glucocorticoid and JNK regulated targets of AP1, in the
acini, may include 
 
 
 
4 integrin expression. Thus, glucocorti-
coid and JNK signaling support the formation of mammary
epithelial acini.
 
Results
 
Formation of mammary epithelial acini
 
Primary mouse mammary epithelial cells cultured on con-
centrated EHS ECM formed 3D cell clusters, as judged by
phase-contrast microscopy (Fig. 1 A, i), whereas cells plated
on diluted EHS ECM formed a monolayer (Fig. 1 A, ii).
Maturation of these structures occurs within 4 d (Fig. 1 B):
DAPI staining (top) and vital dye staining (bottom; Deb-
nath et al., 2002) shows death of the internal lumenal cells
(ethidium bromide [EtBr] staining) contrasting with even-
tual survival of the outer monolayer of cells (Calcein AM,
green staining). Mature cell clusters consist of polarized
acini, as judged by association of laminin with the basal sur-
face, lateral distribution of E-cadherin and the apical distri-
bution of their actin cytoskeleton (Fig. 1 C, i, ii, and iii).
That clearing of the lumen involves apoptosis was suggested
by cleaved caspase 3 expression in the lumenal cells of the
early forming spheres (Fig. 1 C, iv). Treatment of the cul-
tures with prolactin induced milk protein secretion into the
lumen of the spheres (Fig. 1 C, v, 
 
 
 
-casein staining).
 
Glucocorticoids are required for formation
of mammary epithelial acini
 
In contrast to the norm, omitting hydrocortisone from the
cultures resulted, after 4 d, in more disordered assemblies
Figure 1. Mammary epithelial cells cultured on concentrated EHS 
ECM form functional acini. (A) Phase-contrast microscopy of primary 
mouse mammary epithelial cells cultured on concentrated EHS 
ECM (i) and on EHS ECM diluted (1:1.4) (ii) for 4 d (10X). Bar, 50  m. 
(B) Time course of acinus formation from dispersed cells (1–4 d), 
fluorescence microscopic analysis (staining: DAPI; and Calcein AM 
and EtBr; 40X). Bar, 20  m. (C) Fluorescence microscopic analysis 
of 4 d acini stained with anti–laminin V (i), anti–E-cadherin antibody 
(ii), phalloidin-FITC (iii), anticleaved caspase 3 (iv; all 40X; bar, 20 
 m) and anti– -casein antibody (v; 20X; bar, 10  m). 
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Figure 2.
 
Generation of acini requires glucocorticoids.
 
 (A) Fluorescence microscopic analysis of 4 d acini stained with DAPI (left), anti–
 
 
 
-catenin 
antibody (middle) and merged image (right) cultured from time of seeding in the presence (
 
 
 
HC; row 1) and absence (
 
 
 
HC; row 2) of hydro-
cortisone (all 40X). Bar, 10 
 
 
 
m. Rows 3 and 4, same as above but stained with DAPI (left), anti–laminin V antibody (middle), and merged image 
(right). (B) RT-PCR analysis of total RNA isolated from 4 d acini cultured in the presence and absence of hydrocortisone for cyclin D1 and p21 
transcripts (i); and 2 and 4 d acini and 2 d acini cultured in the absence of hydrocortisone (2d-HC) for occludin, ZO1, ZO2, and ZO3 transcripts 
(ii). GAPDH mRNA levels were measured as a control for equal input amounts of RNA. No reverse transcriptase (RT) added controls, lanes (
 
 
 
), 
 
Figure 2 legend continues on next page. 
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showing less defined cell–cell association with incomplete
lumen formation (Fig. 2 A, compare DAPI in rows 1 and 3
with DAPI in rows 2 and 4). In addition, polarized lateral
 
 
 
-catenin distribution and basal laminin association was lost
(Fig. 2 A, compare 
 
 
 
-catenin and Laminin in rows 1 and 3
with 
 
 
 
-catenin and Laminin in rows 2 and 4).
Glucocorticoids were also required for maintenance of p21
RNA transcript expression in the acini (Fig. 2 B, i). p21 ex-
pression, which had been correlated with functional organiza-
tion of mammary epithelial acini (Weaver et al., 1997), was
apparent in 4 d acini, whereas cyclin D1 expression was re-
ciprocally lost. This pattern was reversed in the absence of hy-
drocortisone (Fig. 2 B, i). Cyclin D1 is selectively required
for successful mammary alveolar epithelial cell proliferation
in pregnancy and its expression is positively regulated by nu-
clear factor kB (NF
 
 
 
B; Guttridge et al., 1999; Cao et al.,
2001). Acinar expression of the tight junction protein tran-
scripts, occludin, ZO1 and ZO3, was also glucocorticoid de-
pendent (Fig. 2 B, ii). ZO2 expression was constitutive. In
addition, ZO1 and occludin protein expression was glucocor-
ticoid dependent (Fig. 2 B, iii), in this context.
Lastly, organization of the cells into acini had an associ-
ated transcription factor expression profile: it caused loss of
NF
 
 
 
B-DNA binding activity which was not seen in epithe-
lial cell monolayers formed on dilute EHS ECM, or in
monolayers overlaid with matrix or monolayers cultured on
plastic (Fig. 2 C, compare lanes 3 and 4 with lanes 5 and 6;
compare lanes 7 and 8 with lane 2). In addition, acinar ex-
tracts contained AP1 DNA binding complexes not seen in
the monolayer cultures (Fig. 2 D, compare lanes 3 and 4
with 5 and 6; compare lanes 7 and 8 with lane 2). Omission
of glucocorticoids from the acinar cultures led to the loss of
this profile: NF
 
 
 
B was abundant in the absence of glucocor-
ticoids and different AP1 DNA complexes detected (Fig. 2,
C and D, compare lane 9 with lane 10). The AP1 and
NF
 
 
 
B complexes were shown to be DNA binding site spe-
cific as excess of unlabeled binding element DNA competed
away the complexes, whereas nonspecific competitor oligo-
nucleotides did not (unpublished data). Retention of active
NF
 
 
 
B in glucocorticoid-minus acini correlated with loss of
I
 
 
 
B
 
 
 
 and IKK
 
 
 
 activation (unpublished data).
The AP1 transcription factor complexes detected should
most likely contain c-Jun. Total c-Jun levels remained
constant in the acini and were unaffected by glucocorticoid
receptor inhibition (Fig. 2 E, ii). However, c-Jun was
phosphorylated on a JNK substrate site (ser63) in a glu-
cocorticoid-dependent manner (Fig. 2 E, i). Because the
total c-Jun band runs at 
 
 
 
43 kD and the phospho(ser63)-c-
Jun at 48 kD we conclude that the c-Jun phosphorylated on
ser63 represents only a part of the total cellular c-Jun, a
“phosphorylated” pool (Binetruy et al., 1991). In contrast,
levels of phospho-JunD and JunD were not consistently af-
fected by RU486 treatment (Fig. 2 E, iii and iv), nor were
JunB and phospho-JunB (not depicted). That the AP1 com-
plexes might contain c-Jun phosphorylated by JNK is sup-
ported by our later identifying JNK activation as being glu-
cocorticoid dependent in the acini (see next section).
 
JNK activity is required for mammary epithelial 
acinus formation
 
Acini generated in the presence of the specific JNK inhibi-
tor, SP600125 (Bennett et al., 2001), failed to clear their lu-
mena and to exhibit polarized F-actin, E-cadherin, 
 
 
 
-cate-
nin, 
 
 
 
4 integrin, and ZO-1 distribution (Fig. 3 A, compare
left column with middle column). The glucocorticoid recep-
tor antagonist, RU486, had a similar effect (Fig. 3 A, i, right
column). That this effect is specific to MAPK–JNK pathway
activity is suggested by the fact that 2 d acini forming in the
presence of the ERK–MAPK pathway inhibitor (PD98059)
or p38 inhibitor (SB230580) show normal vital dye distri-
bution (Fig. 3 A, ii) in contrast to acini formed in the pres-
ence of SP600125 which show a disturbed EtBr staining.
Inhibition of JNK activity with SP600125 also transiently
impaired expression of the acinus-associated AP1 complex
and this was accompanied by the transient reappearance of a
slower migrating AP1 complex (Fig. 3 B, i). In addition, it
caused a transient maintenance of the NF
 
 
 
B complex in
acini formed in its presence (Fig. 3 B, ii). We do not pres-
ently know why these changes are only transient in the acini
and not longer lasting.
While JNK inhibition impaired acinus formation, JNK
phosphorylation on p-thr183 and p-tyr185 (which leads to
its activation) was detected in normal acini (Fig. 3 C) but
not in acini generated in the absence of hydrocortisone (or
in mammary epithelial cells maintained as monolayers on
plastic; Fig. 3 C, lanes 2d-HC and M, respectively). SP600125
also inhibited phosphorylation of c-Jun on the JNK sub-
strate site (ser63; Fig. 3 D, i) but did not inhibit acinus-asso-
ciated activation of JNK (phosphorylation on thr183/tyr185;
Fig. 3 D, iii) nor ERK phosphorylation (Fig. 3 D, v). Thus,
a degree of specificity of action of SP600125 in this context
is evident.
 
Glucocorticoids induce BRCA1 and growth arrest and 
DNA damage inducible (GADD45) 
 
  
 
expression and 
activate JNK in acini
 
Rajan et al. (1996) observed glucocorticoid-dependent
BRCA1 expression in differentiated HC11 mammary epi-
thelial cells and Harkin et al. (1999) showed that BRCA1
overexpression induced the DNA damage-associated regula-
tor, GADD45
 
 
 
, and subsequent JNK activation to trigger
 
show absence of DNA contamination. (iii) Western analyses of ZO1 and occludin in 2 and 4 d acini and in acini cultured in the presence of 
RU486 (50
 
  
 
M; RU). 
 
 
 
-Actin was measured as a loading control. (C) EMSA analysis, using a 
 
32
 
P-labeled NF
 
 
 
B-DNA binding element, performed 
on whole cell extracts from mammary epithelial cells at harvest (H, lane 1), cells maintained as monolayers on plastic (M, lane 2), cells cultured 
on concentrated EHS ECM (acini) for 2 and 4 d (lanes 3 and 4), monolayers on dilute EHS ECM matrix (lanes 5 and 6), monolayers on plastic 
overlaid with the EHS ECM matrix (lanes 7 and 8), and acini cultured in the presence of (
 
 
 
) and absence of (
 
 
 
HC) hydrocortisone (lanes 9 and 
10). Arrowheads indicate NF
 
 
 
B complexes. P
 
NF
 
 
 
B
 
 indicates binding element. In this and subsequent figures all discontinuities in gel images are 
marked with a vertical line. (D) EMSA analysis, as C, but using 
 
32
 
P-labeled AP1-DNA binding element. Light colored arrowheads indicate 
acinus-associated complexes. (E) Western analysis of phospho(ser63)-c-Jun (i), total c-Jun (ii), IP (JunD)/Western (anti–phospho-serine) (iii), and 
IP (JunD)/Western (JunD) (iv), in 2 and 4 d acini and in acini cultured in the presence of RU486 (50 
 
 
 
M; RU). 
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apoptosis in a cultured mammary tumor cell line. GADD45
proteins associate with multiple cellular proteins, includ-
ing proliferation cell nuclear antigen (Smith et al., 1994),
p21 (Kearsey et al., 1995), and the MAPK kinase kinase,
MEKK4 (Takekawa and Saito, 1998). Thus, glucocorticoid-
dependent BRCA1 and GADD45
 
 
 
 expression was exam-
ined: BRCA1 mRNA was found in 2 d acini but was not de-
tectable in mammary epithelial cells cultured as a monolayer
on plastic or in 2 d acini formed in the absence of hydrocor-
tisone (Fig. 4 A, i). BRCA1 protein expression was found, in
parallel, in 2 d acini and again its presence was hydrocorti-
sone dependent (Fig. 4 A, ii). GADD45
 
 
 
 (mRNA and pro-
tein) expression was similar and was also glucocorticoid de-
pendent (Fig. 4 B).
Activation of JNK is catalyzed by the MAPK-kinase,
MKK-4/SEK1 (Sanchez et al., 1994), whose activity is in
turn regulated by MEKK4 (Gerwins et al., 1997). Mita et al.
(2002) have shown that MEKK4 is activated by alleviating
its autoinhibition. This occurs on formation of GADD45
 
 
 
–
MEKK4 complexes (Fig. 4 C, i). MEKK4 was expressed in
2 and 4 d acini (Fig. 4 C, ii). Formation of GADD45
 
 
 
–
MEKK4 complexes was analyzed by immunoprecipitation
with an anti-MEKK4 antibody and detection of GADD45
 
 
 
by immunoblotting. GADD45
 
 
 
–MEKK4 complexes were
generated in the 2 and 4 d acini in a hydrocortisone-depen-
dent manner (Fig. 4 C, iii). These complexes were not de-
tectable in monolayers cultured on plastic (Fig. 4 C, lane
M). This formation of MEKK4–GADD45
 
 
 
 complexes po-
tentially links GADD45
 
 
 
 to MEKK4-JNK signaling, under
these conditions.
Downstream activation of the MEKK4 substrate, MKK4,
was detected indirectly by demonstrating the induction of
JNK activity. Immobilized GST-c-Jun (amino acids 1–89)
was used to bind activated JNK. After ATP addition and in-
cubation in kinase buffer, Western blot analysis with an anti–
phospho-c-Jun (ser63; JNK target) specific antibody was per-
formed. c-Jun phosphorylation was detected in acini in a
hydrocortisone-dependent manner (Fig. 4 D). Cultures of
Figure 3. Acinus formation requires JNK activity. (A, i) Fluorescence 
microscopic analysis of 4 d acini cultured in the absence ( ) or 
presence of SP600125 (50  M) or RU486 (50  M); staining with 
DAPI (top), rhodamine-phalloidin and DAPI (second from top; both 
40X; bar, 10  m), anti–E-cadherin (FITC) and rhodamine-phalloidin 
(third from top; 20X; bar, 20  m), anti– -catenin and DAPI (fourth 
from top), anti– 4-integrin (FITC) and rhodamine-phalloidin (second 
from bottom; both 40X; bar, 10  m) and anti-ZO1 and DAPI (bottom; 
20X; bar, 20  m). (ii) 2 d acini formed in presence of PD98059 
(10  M), SB230580 (1  M), and SP600125 (50  M) stained with 
Calcein AM and EtBr. Bar, 10  m. (B) EMSA analysis, using AP1 
(left) and NF B (right) binding elements, on extracts from acini 
treated with the JNK inhibitor, SP600125 (50  M), for 1, 4, and 24 h. 
(C) Western analysis of phospho(thr183/tyr185)-JNK and JNK in
extracts from cells at harvest (H), cells maintained as a monolayer 
on plastic (M), 2 and 4 d acini, and 2 d acini in the absence of 
hydrocortisone (2d-HC). (D) Western analysis of phospho(ser63)-
c-Jun (i), c-Jun (ii), phospho(thr183/tyr185)-JNK (iii), JNK (iv), phos-
pho(thr202/tyr204)-ERK (v), and ERK (vi) in 2 and 4 d acini and 2 d 
acini cultured in the presence of SP600125. 
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monolayers of these cells on plastic with or without pervana-
date served as positive and negative controls for this assay
(Fig. 4 D, lanes 
 
 
 
 and 
 
 
 
). Thus, JNK phosphorylation at
MKK4-target sites, thr183/tyr185 (Fig. 3 C), inducing JNK
activation (reflected by phosphorylation of GST-c-Jun), was
detected in the acini and was glucocorticoid dependent.
To confirm that BRCA1 expression was activated by glu-
cocorticoids upstream of JNK activation, it was shown by
RT-PCR analysis that RU486 treatment blocked BRCA1
transcript expression but that SP600125 had no effect (Fig.
5 A, i). BRCA1 regulates GADD45
 
 
 
 transcription through
its interaction with transcription factors of the OCT family.
Disruptions in the octamer/OCT-1 binding region abolish
activation of the GADD45
 
 
 
 promoter by BRCA1 (Fan et
al., 2002). To test whether BRCA1 was recruited to the
GADD45
 
 
 
 promoter in acini in a glucocorticoid-depen-
dent manner chromatin immunoprecipitation (ChIP) analy-
sis (Boyd and Farnham, 1999) was performed. BRCA1 was
found to be associated in situ with the GADD45
 
 
 
 pro-
moter, in 2 d acini, by PCR detection of GADD45
 
 
 
 pro-
moter fragments (encompassing the OCT binding element)
after anti-BRCA1 antibody ChIP (Fig. 5 A, ii). BRCA1 was
not associated with the GADD45
 
 
 
 promoter in acini gener-
ated in the presence of RU486. In addition, the association
of BRCA1 with another of its established promoter targets,
the p21 promoter (Somasundaram et al., 1997), was also
found to be glucocorticoid dependent (Fig. 5 A, iii).
We had observed that differentiation of mammary epithe-
lial cells (HC11) with dexamethasone and prolactin triggered
expression from an AP1 sensitive promoter-reporter system
(unpublished data). Expression from a transiently transfected
AP1-dependent promoter-reporter (luciferase) construct, in
the acini, was also glucocorticoid dependent (Fig. 5 A, iv and
Fig. 5 B): it was reduced by RU486 (Fig. 5 A, iv and Fig. 5
B) or in the absence of hydrocortisone (Fig. 5 B). Co-
transfection with an expression vector encoding functional
BRCA1 had no significant affect on AP1 reporter gene ex-
pression but cotransfection with an expression vector encod-
ing a naturally occurring “dominant-negative” BRCA1 mu-
tant, Q1756insC (Somasundaram et al., 1997), significantly
decreased AP1-dependent luciferase activity (Fig. 5 A, iv).
The Q1756insC mutation is an insertion of a cytosine in
codon 1756 (in exon 20) that induces a frameshift and dis-
ables the transcriptional activating capacity of BRCA1 that
resides in the COOH terminus (Monteiro et al., 1996).
Thus, expressing a transactivating defective BRCA1 impeded
a glucocorticoid-dependent output in the forming acini.
Expressing a dominant-negative, kinase defective MEKK4
had a similar effect (Fig. 5 B): expression of functional
MEKK4 did not significantly affect reporter gene expres-
sion but cotransfection of an expression vector encoding a
dominant-negative MEKK4 (Gerwins et al., 1997) signif-
icantly repressed AP1-dependent luciferase activity. This
functionally links a requirement for the potential to ac-
tivate the MEKK4 signaling pathway to a glucocorticoid
action in the acini. Finally, it was shown that the GADD
45
 
 
 
–MEKK4 complex was generated in the presence of
SP600125 (Fig. 5 C) demonstrating that activation of JNK
occurred downstream of GADD45
 
 
 
 association with MEKK4
in the acini.
Figure 4. Glucocorticoids support BRCA1 and 
GADD45  expression and GADD45 –MEKK4 
complex formation in acini. (A, i) RT-PCR analysis 
of BRCA1 mRNA levels in cells maintained on plastic 
under proliferating conditions (M), in 2 and 4 d 
acini and acini cultured for 2 d in the absence of 
hydrocortisone (2d-HC). GAPDH and no RT added 
controls as Fig. 2 B, i. (ii) Western analysis of BRCA1 
in cells at harvest (H), cells cultured as a monolayer 
on plastic (M), 2 and 4 d acini, and acini cultured 
for 2 d in the absence of hydrocortisone (2d-HC). 
(B, i) RT-PCR analysis of GADD45  mRNA levels 
(A, i). (ii) Western analysis of GADD45  levels (A, ii). 
(C, i) Diagram: release of MEKK4 autoinhibition by 
GADD45  binding (Mita et al., 2002). (ii) Western 
analysis of MEKK4 levels (A, ii). (iii) Analysis of 
MEKK4–GADD45  complexes. Complexes were 
immunoprecipitated from cell extracts with anti-
MEKK4 at harvest (H), from cells maintained on 
plastic (M), 2 and 4 d acini, and acini cultured for 
2 d in the absence of hydrocortisone (2d-HC); fol-
lowed by anti-GADD45  immunoblot. (D) JNK 
activity assay: JNK was harvested onto GST-c-Jun 
(amino acids 1–89) beads from extracts of cells at 
harvest (H), from cells maintained on plastic under 
proliferating conditions (M), 2 and 4 d acini, and 
acini cultured for 2 d in the absence of hydrocorti-
sone (2d-HC). Shown is the anti–phospho-c-Jun 
immunoblot performed after incubation of the 
JNK–GST-c-Jun bead complexes with ATP. Cell 
cultures treated with ( ) and without ( ) pervanadate 
(25 mM) were used as a positive and negative 
control, respectively. 
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4 integrin expression: a downstream target of the 
glucocorticoid and JNK action
 
Potapova et al. (2002) reported that  4 integrin expression is
regulated by JNK signaling in human PC3 prostate carcinoma
cells. Because  4 integrin expression has been documented to
be vital for acinus formation (Weaver et al., 2002), the possi-
bility that it is a downstream target of the glucocorticoid and
JNK signaling was examined.  4 integrin mRNA was not de-
tected in RU486 treated 2 d acini and its levels were reduced
on SP600125 treatment (Fig. 6 A, i).  4 integrin protein lev-
els were also decreased in 2 d acini treated with SP600125 and
undetectable with RU486 treatment (Fig. 6 A, ii). The mouse
 4 integrin promoter contains multiple AP1 DNA binding
elements. Using ChIP analysis, in situ occupation of the  4
integrin promoter in 2 d acini by c-Jun and c-Fos was demon-
strated and this occupation was glucocorticoid receptor and
JNK dependent (Fig. 6, B and C). This suggests that mainte-
nance of  4 integrin expression is a potential target of gluco-
corticoid and JNK signaling in the developing acini.
BRCA1, GADD45  and phospho-JNK expression 
in the pregnancy/lactation transition in the mouse 
mammary gland
Mouse mammary acini are in vitro alveolar-like structures
that functionally mimic the differentiated epithelial alveoli
of the early lactating mammary gland. It was of interest to
see if selective BRCA1, GADD45 , and phospho-JNK ex-
pression was associated with the pregnancy/lactation transi-
tion in the mammary gland, in vivo. Western blot analysis of
cell extracts showed that BRCA1 and GADD45  were not
detectable in whole cell extracts from late pregnancy mam-
mary gland but expression of these proteins in cell extracts
was detectable on day 1 of lactation (Fig. 7 A, top and sec-
ond from top). JNK phosphorylation, reflecting the activa-
tion of JNK–MAPK pathway, had a slightly broader expres-
sion range. It was detected in late pregnancy (day 18, but
not on day 16), and up to 3 d into lactation (Fig. 7 A, third
from top). Finally, using ChIP analysis, it could be seen that
BRCA1 is recruited to the GADD45  and p21 promoter
Figure 5. Analysis of glucocorticoid signaling in 
acini. (A, i) RT-PCR analysis of BRCA1 mRNA levels 
in acini cultured for 1 and 2 d, acini formed for
2 d in the absence of hydrocortisone (2d-HC), and 
2 d acini cultured in the presence of RU486 and 
SP600125 (Fig. 2 B, i). (ii and iii) ChIP analysis of 
BRCA1 occupation of the GADD45  or p21 pro-
moters in acini cultured for 2 d in the presence and 
absence of glucocorticoid receptor function ( HC   
RU486). IP was with anti-BRCA1 antibody ( )
or no antibody ( ). After reversal of cross-linking, 
DNA recovered from the chromatin was analyzed 
by PCR using primers specific for the GADD45  
(ii) and p21 (iii) promoters (see diagrams). Promoter 
DNA purified from sheared chromatin “input” to 
the IP is shown as control. (iv) Relative luciferase 
activity in extracts of acini formed from cells 1 d 
after suspension transfection with the pAP1-luciferase 
(1.0  g) ( ), transfected and treated with RU486, 
cotransfected with pCR3-BRCA1 (1.0  g) (wtBRCA1) 
and cotransfected with the BRCA1 mutant 
expression vector, pCR3-BRCA1-Q1756insC (1.0  g) 
(mBRCA1). ***, indicates value to be significantly 
(P   0.05; n   3; t test) less than lane ( ). (B) Relative 
luciferase activity in extracts of acini formed from 
cells 1 d after suspension transfection with the 
pAP1-luciferase (1.0  g) ( ), transfected in the 
absence of hydrocortisone ( HC) or treated with RU486, cotransfected with pCMV5-MEKK4 
(1.0  g) and cotransfected with the MEKK4 dominant-negative mutant expression vector, pCMV5-
 MEKK4 kin
  (1.0  g). ***, same as A iv, above. (C) Analysis of MEKK4–GADD45  complexes. 
Complexes were immunoprecipitated with anti-MEKK4 antibody from cell extracts from 2 d 
acini, 2 d acini cultured in the presence of SP600125 ( SP) and cells maintained as a mono-
layer on dilute EHS ECM (M) and followed by anti-GADD45  immunoblot.140 The Journal of Cell Biology | Volume 166, Number 1, 2004
primarily in the early lactating mammary gland (Fig. 7 B).
These results support the possibility that JNK signaling is
activated in the transition from pregnancy to lactation in the
mouse mammary gland, in vivo.
Discussion
Debnath et al. (2002) suggest that a primary event in acinus
formation is establishment of epithelial cell polarity and that
this triggers the restriction in cell proliferation and the apop-
totic activity that are required for acinus maturation and lu-
men formation. The establishment of polarity in epithelial
cells most probably goes hand-in-hand with the develop-
ment of cell–cell contacts through apical junctions (O’Brien
et al., 2002). Firestone and coworkers (Buse et al., 1995;
Wong et al., 1999; Woo et al., 1999; Rubenstein et al.,
2003) suggest that in mammary tumor cell monolayers, glu-
cocorticoids induce tight junction formation and cell polar-
ity through a multi-step cascade involving early rapid stim-
ulation of the transcriptional regulator, Id-1, and later
induced recruitment of tight junction proteins, adherens
junction proteins and Ras and PI3 kinase signaling proteins
to the sites of cell–cell contact (Woo et al., 1999). This par-
allels necessary down-regulation of fascin, an adherens junc-
tion-associating actin-bundling protein (Wong et al., 1999).
This work suggests that glucocorticoids act to support acinus
formation and may do this by regulating the expression of
proteins required for cell–cell (ZO-1 and occludin) and
ECM–cell contacts ( 4 integrin).
Acinus formation was accompanied by JNK phosphoryla-
tion (Fig. 3 C) and activation (Fig. 4 D) and this effect was
lost when glucocorticoid receptor function was inhibited.
However, there remains the possibility that loss of glucocor-
ticoid receptor function primarily undermines morphologi-
cal activities such as establishment of cell–cell junctions, sig-
naling from which might support JNK activation. Thus,
there is the possibility that the glucocorticoid-modulated ac-
tivation of JNK is indirect. Inhibition of JNK activity with
SP600125 had similar effects to inhibiting glucocorticoid re-
ceptor function both on acinus morphology and transcrip-
tion factor binding activity. But note must be taken that
SP600125 has been shown to act with similar potency on a
range of other kinases in the studies of Bain et al. (2003).
However, it was the only one of the three inhibitors of Erk,
p38, and JNK–MAPK pathway activities, respectively, to in-
hibit acinus formation in this work (Fig. 3 A, ii).
BRCA1 and GADD45  expression were induced during
acinus maturation (Fig. 4) and the absence of BRCA1 tran-
scripts in acini treated with RU486 but their presence on
SP600125 treatment (Fig. 5 A, i) defined the induction of
BRCA1 expression as upstream of JNK. Also, using ChIP
analysis, the in situ association of BRCA1 with the GADD
45  promoter in a glucocorticoid-dependent manner was
demonstrated. The formation of GADD45 –MEKK4 com-
plexes, which is reported to relieve autoinhibition of the
MEKK4 kinase and permit JNK-pathway activation (Mita
et al., 2002), occurred in the acini and was glucocorticoid
dependent (Fig. 4 C, iii). The detection of their presence es-
tablished a potential physical link between the glucocorti-
Figure 6.  4 integrin expression, a target for glucocorticoid and 
JNK regulation. (A, i) RT-PCR analysis of  4 integrin RNA in 2 d 
acini ( ) and 2 d acini treated with RU486 (RU) and SP600125 (SP) 
(Fig. 2 B, i). (ii) Western analysis, using anti– 4 integrin antibody, of 
extracts from 2 and 4 d acini generated in the absence and presence 
of RU486 (RU) and SP600125 (SP).  -Actin expression was measured 
as loading control. (B and C) ChIP analysis of c-Jun and c-Fos occu-
pation of the  4 integrin promoter (see diagram) in acini cultured 
for 2 d in the presence and absence of RU486 and SP600125. 
IP was with anti–c-Jun (B) or anti-Fos antibody (C) (Fig. 5 A, ii).
Figure 7. BRCA1, GADD45 , and phospho-JNK expression in 
pregnancy/lactation transition in the mouse mammary gland. 
(A) Western analysis of whole cell extracts from 16- and 18-d 
pregnant (16dp and 18dp) and 1- and 3-d lactating (1dl and 3dl) 
mammary glands. Analysis was performed using anti-BRCA1 (top), 
anti-GADD45  (second from top), anti–phospho-JNK (third from 
top) and anti-JNK antibodies (bottom). (B) ChIP analysis of BRCA1 
occupation of the GADD45  or p21 promoters (Fig. 5 A, ii and iii) 
in 16- and 18-d pregnant and 1- and 3-d lactating mammary gland. 
IP was with anti-BRCA1 antibody (Fig. 5 A, ii).3D acinus formation requires glucocorticoids | Murtagh et al. 141
coid induction of BRCA1 and GADD45  expression and
JNK pathway signaling in the acini. This is supported by
the inhibition of glucocorticoid-dependent activation of a
transfected AP1-dependent promoter-reporter system by
coexpression of a dominant-negative BRCA1 protein (Fig.
5 A, iv) and a kinase-defective dominant-negative MEKK4
(Fig. 5 B), respectively. This leaves open the possibility that
glucocorticoids signal to activate JNK through modulation
of BRCA1 and GADD45  action during acinus formation.
The late pregnancy/early lactation transition is accompa-
nied by “closure” of epithelial cell–cell junctions to facili-
tate efficient transfer of milk constituents to the alveolar lu-
mina (Nguyen et al., 2001). Lactation is associated with
high circulating glucocorticoid levels (Feng et al., 1995)
and it was of interest that selective BRCA1, GADD45 ,
and phospho-JNK expression could be detected at this tran-
sition (Fig. 7).
A target of the glucocorticoid and JNK signaling was acti-
vation of c-Jun and associated AP1 activation. c-Jun was
phosphorylated on serine-63, a JNK substrate site, in the
acini in a glucocorticoid-dependent manner (Fig. 2 E) and
AP1 activity, as judged by reporter gene expression, was
maintained in a glucocorticoid, BRCA1, and MEKK4-
dependent manner (Fig. 5 A, iv; Fig. 5 B). In addition, glu-
cocorticoid-dependent in situ occupation of the “target”  4
integrin promoter by c-Jun and Fos was seen (Fig. 6). Such
indirect regulation of AP1 activity by glucocorticoids was
unexpected. The direct interactions of activated glucocorti-
coid receptor with AP1 that have been reported are DNA-
binding independent and inhibitory (for review see Karin
and Chang, 2001).
The significant failure of mammary gland development
during pregnancy that is seen in BRCA1 conditional knock-
out mice is suggested to reflect cell loss arising from failure
of DNA damage repair (Xu et al., 1999). Apart from direct
actions in DNA damage repair complexes (for review see
Venkitaraman, 2001), BRCA1 also induces a wide range of
transcriptional responses (Harkin et al., 1999; Fan et al.,
2002). The induction by BRCA1 of the expression of the
DNA damage repair associated regulator, GADD45 , has
been linked experimentally to activation of JNK and apop-
tosis of breast and ovarian tumor cell lines (Harkin et al.,
1999; Thangaraju et al., 2000). However, it seems unlikely
that the only outcome of inducing JNK activation in these
acini would be the induction of apoptosis. This work sug-
gests that JNK signaling is required for establishment or
maintenance of acinar cell function but it may also trigger
apoptosis in those lumenal cells not supported by ECM as-
sociation. Glucocorticoids, and perhaps BRCA1, indepen-
dently of JNK activation, would also seem implicated in the
cell cycle arrest that accompanies acinus maturation. An in-
duction of p21 and suppression of cyclin D1 expression ac-
companies acinus formation and this is glucocorticoid de-
pendent (Fig. 2 B). In addition, BRCA1 occupation of the
p21 promoter, in situ, is glucocorticoid dependent, but it
may not be JNK dependent. BRCA1 regulation of p21 pro-
moter function has been reported previously (Somasun-
daram et al., 1997).
Debnath et al. (2002) emphasize the co-coordinated re-
quirement of both antiproliferative and apoptotic activities,
triggered by cell polarization, to achieve lumen formation in
mammary epithelial acini. The work of Weaver et al. (2002)
demonstrates how these structures are resistant to apoptotic
insults to which some mammary tumor cells or mammary
epithelial cells organized as monolayers readily succumb.
This work suggests that glucocorticoids and JNK activity are
required to support mammary epithelial cells to organize
into functional acini. In the immediate future it will be of
particular interest to identify further downstream targets of
glucocorticoid and JNK signaling in acini. That  4 integrin,
possibly through AP1, and ZO-1 and occludin expression is
regulated by glucocorticoids, suggests a role in maintaining
cell–ECM and cell–cell component expression that are es-
sential for acinus viability. Typically mammary tumor cells
fail to organize as acini (Petersen et al., 1992; Howlett et al.,
1995). It will be of interest to assess responsiveness to gluco-
corticoids and JNK signaling in such cells.
Materials and methods
Cell culture
Mouse mammary epithelial cells were harvested from mid- to late-preg-
nant CD-1 mice as described previously (Furlong et al., 1996). Cells were
seeded on tissue culture dishes coated with concentrated, growth factor
depleted, EHS ECM (Matrigel
®; BD Biosciences; 1.74 mg protein/6 cm
2
plate; or diluted 1:1.4 with F12 medium) at a density of 2.4   10
6 cells/ml
and cultured for 48 h with 5 ng/ml epidermal growth factor (Promega), 5
 g/ml insulin (Sigma-Aldrich), 1  g/ml hydrocortisone (Sigma-Aldrich),
and 50  g/ml gentamycin (Sigma-Aldrich) in F12 medium (Life Technolo-
gies, Inc.). Cells cultured on EHS ECM were washed, and the medium was
changed to: F12, 50  g/ml gentamycin, 5  g/ml insulin, 1  g/ml hydrocor-
tisone, and 3  g/ml prolactin. These cells were harvested after 1–4 d in
culture. Cells cultured on plastic were maintained for 72 h in the initial
medium supplemented with 10% heat inactivated FCS (Life Technologies).
Cells were recovered by scraping and were pelleted by centrifugation. The
cell pellets were snap frozen and stored at  80 C before RNA or protein
extract preparation. 50  M RU486 (Sigma-Aldrich), 50  M SP600125
(Calbiochem), 10  M PD98059 (Calbiochem), and 1  M SB230580 (Cal-
biochem) were added to cells cultured on EHS ECM at the time of plating.
Cell extract preparation, Western blot analysis, 
immunoprecipitation, kinase assays, and 
electrophoretic mobility shift analysis (EMSA)
Whole cell extracts were prepared by resuspending pelleted cells in 50–
100  l of extraction buffer (Furlong et al., 1996). The samples were kept
on ice for 30 min before centrifugation at 14,000 rpm at 4 C for 20 min.
The supernatant constituted the whole cell extract.
Western blot analysis was performed as described previously (Furlong
et al., 1996). Antibodies against BRCA1 (Upstate Biotechnology), occludin
(BD Transduction Laboratories),  4 integrin, and ZO1 (CHEMICON Inter-
national, Inc.), GADD45 , MEKK4, and JunD (Santa Cruz Biotechnology,
Inc.), ERK, phospho-ERK, c-Jun, phospho-c-Jun, JNK, and phospho-JNK
(Cell Signaling Technology), and phospho-serine (Calbiochem), were used
according to the manufacturer’s recommendations.
For immunoprecipitation-Western analysis, cell pellets were resus-
pended in 250  l of NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM
Tris-HCl, pH 8.0) and allowed settle on ice for 30 min before centrifuga-
tion at 14,000 rpm at 4 C for 20 min. The resultant supernatant was incu-
bated with 1  l of anti-MEKK4 or anti-JunD antibody for 1 h on ice. 100  l
of protein A bead suspension (Sigma-Aldrich) was then added to the anti-
body–antigen reaction and incubated at 4 C overnight, with rotation. The
protein A beads were pelleted by brief centrifugation at 14,000 rpm for 15 s
at 4 C and the immunocomplex was washed three times with lysis buffer.
After removing the final wash, 50  l of 2X Laemmli buffer was added and
the samples boiled for 10 min. The samples were then centrifuged at
14,000 rpm for 2 min and the supernatant loaded on a 10% SDS PAGE gel
and Western analysis for the appropriate antigen performed.
For the JNK activity assay, cell extracts were prepared as above and
the assay was performed using a SAPK/JNK assay kit from Cell Signaling
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EMSA was performed as described previously (Furlong et al., 1996) us-
ing 12  g of protein extract and 15,000 cpm of 
32P-end-labeled double
stranded oligonucleotide transcription factor binding elements for AP1
(Marti et al., 1994) and NF B (Geymayer and Doppler, 2000).
RT-PCR analysis
Cultured cells or cell assemblies were gently scraped from the plates, pel-
leted, washed by resuspension in PBS, pelleted, and resuspended in TRI-
zol
® Reagent (Invitrogen). Reverse transcription and limited cycle PCR
were performed as described previously (O’Connell and Martin, 2000).
Primers were designed against murine  4 integrin (fwd, gctgagttggacttg-
gaagc; rev, gtagtgtccttcgagcagcc), BRCA1 (fwd, tcggcgcttgcaagtacggatct;
rev, aaggttagacagctggacaccta), cyclin D1 (fwd, agcagaagtgcgaagaggag;
rev, ctggcattttggagaggaag), GADD45  (fwd, caccctgatccagtcgttct; rev, ttgc-
ctctgctctcttcaca), GAPDH (fwd, accacagtccatgccatcac; rev, tccaccaccctgt-
tgctgta), occludin (fwd, cctactcctccaatggcaaa; rev, aggtggatattccctgaccc),
p21 (fwd, gtccaatcctggtgatgtcc; rev, ctcaggtagaccttgggcag), ZO1 (fwd,
caaaacgctctacaggctcc; rev, gaagagctggacagaggtgg), ZO2 (fwd, tctcaagat-
caacggcactg; rev, tgatcagaatactgctggcg), and ZO3 (fwd, accagctctcagac-
caggaa; rev, ctgactgcctagcttcaccc) using Primer3 software (Rozen and Ska-
letsky, 2000).
Microscopy
For whole acinus microscopy, cells were cultured on concentrated EHS
ECM in 2 well chamber slides (Lab Tek
®). Medium was removed and the
cell assemblies were fixed in situ using 4% PFA. Cells were permeabilized
using 0.1% Triton X-100 for 10 min before blocking in 5% normal serum
(appropriate species). Cells were incubated with primary antibodies (or
phalloidin-FITC or -rhodamine; Molecular Probes) overnight at 4 C and
then with FITC- or rhodamine-conjugated secondary antibodies for 20
min. The primary antibodies used were against:  4 integrin and ZO1
(CHEMICON International, Inc.) and E-cadherin (BD Transduction Labora-
tories). Nuclei were counterstained with DAPI (Sigma-Aldrich). For sec-
tioning, cell assemblies were released from the ECM by gentle scraping,
briefly centrifuged to pellet, and fixed in 10% formalin (Sigma-Aldrich) for
at least 24 h before embedding in paraffin. 5- m sections were cut. Sec-
tions were deparaffinized and treated for either immunoflourescence: sec-
tions were blocked in 5% normal serum and then incubated with primary
antibodies against  -catenin (BD Transduction Laboratories), laminin V
(Sigma-Aldrich),  -casein (a gift from E. Reichman, University of Zurich,
Zurich, Switzerland), and cleaved caspase 3 (Cell Signaling Technology)
overnight at 4 C. Sections were counterstained with DAPI (Sigma-Aldrich).
For vital dye studies, acini were incubated with 10  g/ml EtBr and 10  M
Calcein AM (Molecular Probes) for 10 min at 37 C. Phase contrast and
fluorescence were visualized with an Axiocam HRC (Carl Zeiss Micro-
Imaging, Inc.) mounted on a fluorescence microscope (model DMLB
HBO100; Leica) and images were captured using Axiovision v3.1 software
(Carl Zeiss MicroImaging, Inc.). Confocal microscopy was performed using
a confocal microscope (model MRC 1024; Bio-Rad Laboratories) and im-
ages were captured using Laser Capture software.
Transfection and luciferase assays
Plasmids were transfected into freshly harvested primary mammary epithe-
lial cells suspended in F12 medium, before plating onto EHS, using the Fu-
Gene 6 transfection system (Roche Molecular Biochemicals). Plasmids
used were pAP1-luc (Stratagene), pCMV5-MEKK4, and pCMV5- MEKK4
kin
  (Gerwins et al., 1997; a gift from G. Johnson, University of Colorado
Health Sciences Center, Denver, CO), and pCR3-BRCA1 and pCR3-
BRCA1-Q1756insC (Somasundaram et al., 1997; a gift from B. Weber,
University of Pennsylvania, Philadelphia, PA). The pRL-CMV, renilla lu-
ciferase reporter plasmid (Promega), was cotransfected and its activity used
to correct for variation in transfection efficiency. After 24 h, cells were har-
vested, cell extracts prepared, and luciferase assays were performed using
a Dual-Luciferase® Reporter Assay System (Promega). Statistical analysis
was performed using the t test.
ChIP analysis
Cross-linking ChIP analysis (Boyd and Farnham, 1999) was performed us-
ing a ChIP assay kit purchased from Upstate Biotechnology. Mouse mam-
mary glands were minced with a razor blade, brought up to 10.0 ml with
PBS, and cross-linked for 10 min in a final volume of 1% formaldehyde.
The cross-linking reaction was stopped by the addition of 0.125 M glycine,
the glands pelleted by gentle centrifugation, washed with cold PBS, ho-
mogenized in an ULTRA-TURRAX
® T8 disperser (IKA
®), in 2.0 ml PBS,
transferred to a 1.5 ml tube, centrifuged at 2,000 rpm for 10 min at 4 C,
and the pellet resuspended in 200  l SDS lysis buffer (0.01% SDS, 1.1%
Triton X-100, 1.2 mM EDTA, 16.7 mM Tris, pH 8.1, 16.7 mM NaCl, and 1
 g/ml each of aprotinin, leupeptin, and pepstatin A) on ice for 10 min.
Acini were cross-linked on the cell culture plates by adding 135  l 37%
formaldehyde to the 5.0-ml medium and incubating at 37 C for 10 min.
After glycine addition and washing with cold PBS, the cell assemblies were
scraped from the plates in PBS into a 1.5-ml centrifuge tube and treated
with lysis buffer (as above). Samples were sonicated on ice (setting 15, 3  
10-s pulses; Ultrasonics sonicator) to reduce DNA length to 200–1,000 bp
and centrifuged for 10 min at 14,000 rpm at 4 C. The supernatant was di-
luted 10-fold in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris, pH 8.1, 16.7 mM NaCl, and 1  g/ml each of aproti-
nin, leupeptin, and pepstatin A) and the chromatin precleared with salmon
sperm DNA/protein A agarose (Upstate Biotechnology) for 30 min at 4 C
with agitation. Precleared chromatin solution (1.0 ml) and 5  l antibody
(BRCA1; Upstate Biotechnology), p21 (Santa Cruz Biotechnology, Inc.),
c-Fos (Oncogene), and c-Jun (Cell Signaling Technology) or no antibody
(negative control) were incubated overnight at 4 C with rotation. Before
immunoprecipitation, 50  l of chromatin solution was saved (input chro-
matin) and was processed with the eluted immunoprecipitates beginning
at the cross-link reversal step. The immunocomplexes were collected by
adding 60  l of salmon sperm DNA/protein A agarose and rotating for 1 h
at 4 C. The beads were pelleted by brief centrifugation, washed with low
salt complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20
mM Tris-HCL, pH 8.1, 150 mM NaCl), high salt complex wash buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCL, pH 8.1, 500
mM NaCl), LiCl immunocomplex buffer (0.25 M LiCl, 1% NP-40, 1% so-
dium deoxycholate, 1 mM EDTA, 10mM Tris-HCl, pH 8.1) and TE, pH
8.0, with brief centrifugation between each wash to recover the beads. The
immunocomplexes were eluted from the beads by the addition of 500  l
1% SDS in 0.1 M NaHCO3 to pelleted beads, vortexing and rotating at RT
for 30 min. To reverse the cross-linking process, 200 mM NaCl was added
to the eluates which were incubated at 65 C for 4 h. 10 mM EDTA, 40 mM
Tris-HCL, pH 6.5, and 2  l of 10 mg/ml Proteinase K was then added and
incubated at 45 C for 1 h. DNA was recovered by phenol/chloroform ex-
traction and ethanol precipitation. Promoter sequences were detected in
immunoprecipitated and input DNA by PCR using specific primers:
GADD45  (fwd, gatgctagggtgccttggta; rev, cctagcctttcccaagctct), p21 (fwd,
gtatgctgccacaaccacac; rev, ccatcaggccaatcaaaagt), and  4-integrin (fwd,
tgaagtttgtcagcaggc; rev, ttcatgcgtatcagccat). Parallel ChIP analyses for each
promoter was performed using an antiacetylated histone antibody as a
positive control.
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